{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T12:24:19Z","timestamp":1765974259701,"version":"3.32.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1016\/j.pbb.2005.10.004","type":"journal-article","created":{"date-parts":[[2005,11,19]],"date-time":"2005-11-19T12:15:24Z","timestamp":1132402524000},"page":"488-494","source":"Crossref","is-referenced-by-count":11,"title":["2-Phenylethylamine in combination with l-deprenyl lowers the striatal level of dopamine and prolongs the duration of the stereotypy in mice"],"prefix":"10.1016","volume":"82","author":[{"given":"Junichi","family":"Kitanaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobue","family":"Kitanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Tatsuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motohiko","family":"Takemura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2005.10.004_bib1","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF00979534","article-title":"In vivo release of endogenous dopamine, 5-hydroxytryptamine and some of their metabolites from rat caudate nucleus by phenylethylamine","volume":"12","author":"Bailey","year":"1987","journal-title":"Neurochem Res"},{"key":"10.1016\/j.pbb.2005.10.004_bib2","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1471-4159.2004.02501.x","article-title":"Mammalian central nervous system trace amines. Pharmacologic amphetamines, physiologic neuromodulators","volume":"90","author":"Berry","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.pbb.2005.10.004_bib3","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0024-3205(77)90431-3","article-title":"Chronic phenylethylamine stereotypy in rats: a new animal model for schizophrenia?","volume":"21","author":"Borison","year":"1977","journal-title":"Life Sci"},{"key":"10.1016\/j.pbb.2005.10.004_bib4","first-page":"119","article-title":"Phenylethylamine in the CNS: effects of monoamine oxidase inhibiting drugs, deuterium substitution and lesions and its role in the neuromodulation of catecholaminergic neurotransmission","volume":"29","author":"Boulton","year":"1990","journal-title":"J Neural Transm (Suppl)"},{"key":"10.1016\/j.pbb.2005.10.004_bib5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0014-2999(75)90238-1","article-title":"The monoamine oxidase B inhibitor deprenyl potentiates phenylethylamine behavior in rats without inhibition of catecholamine metabolite formation","volume":"34","author":"Braestrup","year":"1975","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2005.10.004_bib6","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/0028-3908(81)90098-8","article-title":"Behavioural effects of acute and chronic beta-phenylethylamine administration in the rat: evidence for the involvement of 5-hydroxytryptamine","volume":"20","author":"Dourish","year":"1981","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2005.10.004_bib7","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1476-5381.1982.tb09278.x","article-title":"A pharmacological analysis of the hyperactivity syndrome induced by beta-phenylethylamine in the mouse","volume":"77","author":"Dourish","year":"1982","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pbb.2005.10.004_bib8","first-page":"137","article-title":"Modification of dopamine release by selective inhibitors of MAO-B","volume":"8","author":"Finberg","year":"2000","journal-title":"Neurobiology (Budapest)"},{"key":"10.1016\/j.pbb.2005.10.004_bib9","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0166-2236(00)01886-5","article-title":"Genetic animal models: focus on schizophrenia","volume":"24","author":"Gainetdinov","year":"2001","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.pbb.2005.10.004_bib10","doi-asserted-by":"crossref","first-page":"S137","DOI":"10.1212\/WNL.47.6_Suppl_3.137S","article-title":"Pharmacology of selegiline","volume":"47","author":"Gerlach","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.pbb.2005.10.004_bib11","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.2042-7158.1972.tb09012.x","article-title":"The effect of beta-phenethylamine upon spontaneous motor activity in mice: a dual effect on locomotor activity","volume":"24","author":"Jackson","year":"1972","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.pbb.2005.10.004_bib12","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1523\/JNEUROSCI.18-06-01979.1998","article-title":"Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter","volume":"18","author":"Jones","year":"1998","journal-title":"J Neurosci"},{"key":"10.1016\/j.pbb.2005.10.004_bib13","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0014-2999(03)02015-6","article-title":"Behavioral sensitization and alteration in monoamine metabolism in mice after single versus repeated methamphetamine administration","volume":"474","author":"Kitanaka","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2005.10.004_bib14","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.neuroscience.2004.09.026","article-title":"Inhibition of methamphetamine-induced hyperlocomotion in mice by clorgyline, a monoamine oxidase-A inhibitor, through alteration of the 5-hydroxytryptamine turnover in the striatum","volume":"130","author":"Kitanaka","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2005.10.004_bib15","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0091-3057(95)02230-9","article-title":"Antagonism by CPP, (\u00b1)-3-(2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid, of beta-phenylethylamine (PEA)-induced hypermotility in mice of different strains","volume":"55","author":"Lapin","year":"1996","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2005.10.004_bib16","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0022-3565(24)38016-4","article-title":"l-Methamphetamine pharmacokinetics and pharmacodynamics for assessment of in vivo deprenyl-derived l-methamphetamine","volume":"288","author":"Melega","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2005.10.004_bib17","first-page":"731","article-title":"Dose\u2013response effects of beta-phenylethylamine on stereotyped behavior in pargyline-pretreated rats","volume":"11","author":"Moja","year":"1976","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pbb.2005.10.004_bib18","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1254\/jphs.FPJ04040X","article-title":"Effects of dopamine- and serotonin-related compounds on methamphetamine-induced self-injurious behavior in mice","volume":"96","author":"Mori","year":"2004","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.pbb.2005.10.004_bib19","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0014-2999(98)00191-5","article-title":"Characterization of beta-phenylethylamine-induced monoamine release in rat nucleus accumbens: a microdialysis study","volume":"349","author":"Nakamura","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2005.10.004_bib20","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/BF00432018","article-title":"Phenylethylamine-induced stereotypies in the rat: a behavioral test system for assessment of MAO-B inhibitors","volume":"84","author":"Ortmann","year":"1984","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2005.10.004_bib21","first-page":"199","article-title":"Comparative effects of amphetamine, phenylethylamine and related drugs on dopamine efflux, dopamine uptake and mazindol binding","volume":"245","author":"Parker","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2005.10.004_bib22","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1111\/j.1471-4159.1990.tb05764.x","article-title":"2-Phenylethylamine: a modulator of catecholamine transmission in the mammalian central nervous system?","volume":"55","author":"Paterson","year":"1990","journal-title":"J Neurochem"},{"key":"10.1016\/j.pbb.2005.10.004_bib23","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1471-4159.1979.tb11718.x","article-title":"The effect of monoamine oxidase inhibitors on some arylalkylamines in rat striatum","volume":"33","author":"Philips","year":"1979","journal-title":"J Neurochem"},{"key":"10.1016\/j.pbb.2005.10.004_bib24","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1126\/science.504988","article-title":"Phenylethylamine in paranoid chronic schizophrenia","volume":"206","author":"Potkin","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.pbb.2005.10.004_bib25","series-title":"Amphetamines and related compounds","first-page":"695","article-title":"Biochemical, anatomical and psychological investigations of stereotyped behavior induced by amphetamines","author":"Randrup","year":"1970"},{"key":"10.1016\/j.pbb.2005.10.004_bib26","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0165-0173(86)90002-0","article-title":"Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis","volume":"11","author":"Robinson","year":"1986","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.pbb.2005.10.004_bib27","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/0006-2952(78)90543-9","article-title":"Phenylethylamine and brain function","volume":"27","author":"Sabelli","year":"1978","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pbb.2005.10.004_bib28","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1146\/annurev.pa.33.040193.003231","article-title":"Amphetamine: effects on catecholamine systems and behavior","volume":"32","author":"Seiden","year":"1993","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.pbb.2005.10.004_bib29","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1471-4159.2004.02721.x","article-title":"Dopamine transporter-dependent and -independent actions of trace amine beta-phenylethylamine","volume":"91","author":"Sotnikova","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.pbb.2005.10.004_bib30","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0003-2697(76)90070-1","article-title":"A fluorometric assay for beta-phenylethylamine in rat brain","volume":"75","author":"Suzuki","year":"1976","journal-title":"Anal Biochem"},{"key":"10.1016\/j.pbb.2005.10.004_bib31","doi-asserted-by":"crossref","unstructured":"Tatsuta T, Kitanaka N, Kitanaka J, Morita Y, Takemura M. Effects of monoamine oxidase inhibitors on methamphetamine-induced stereotypy in mice and rats. Neurochem Res: in press.","DOI":"10.1007\/s11064-005-8390-2"},{"key":"10.1016\/j.pbb.2005.10.004_bib32","first-page":"50","article-title":"The effect of repeated administration of (-)deprenyl on the phenylethylamine-induced stereotypy in rats","volume":"279","author":"Tim\u00e1r","year":"1986","journal-title":"Arch Int Pharmacodyn"},{"key":"10.1016\/j.pbb.2005.10.004_bib33","doi-asserted-by":"crossref","first-page":"13873","DOI":"10.1073\/pnas.212519999","article-title":"Mice with chronic norepinephrine deficiency resemble amphetamine-sensitized animals","volume":"21","author":"Weinshenker","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pbb.2005.10.004_bib34","first-page":"365","article-title":"Beta-phenylethylamine: a specific substrate for type B monoamine oxidase of brain","volume":"187","author":"Yang","year":"1973","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2005.10.004_bib35","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0165-1781(87)90027-8","article-title":"Urinary trace amine excretion and platelet monoamine oxidase activity in schizophrenia","volume":"21","author":"Yoshimoto","year":"1987","journal-title":"Psychiatry Res"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305705003357?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305705003357?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T19:17:39Z","timestamp":1736104659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305705003357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["S0091305705003357"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2005.10.004","relation":{},"ISSN":["0091-3057"],"issn-type":[{"type":"print","value":"0091-3057"}],"subject":[],"published":{"date-parts":[[2005,11]]}}}